申请人:——
公开号:US20020183369A1
公开(公告)日:2002-12-05
This invention relates to compounds of Formula I
1
or stereoisomers, pharmaceutically acceptable salts or prodrugs thereof or a pharmaceutically acceptable salts of the prodrugs. This invention also relates to pharmaceutical compositions comprising a compound of Formula I, and to methods of treatment of diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis, or tissue ischemia.
本发明涉及公式I1的化合物或其立体异构体,其药学上可接受的盐或前药的药学上可接受的盐。本发明还涉及包含公式I的化合物的制药组合物,以及治疗糖尿病、胰岛素抵抗、糖尿病神经病变、糖尿病肾病、糖尿病视网膜病变、白内障、高血糖、高胆固醇血症、高血压、高胰岛素血症、高脂血症、动脉硬化或组织缺血的治疗方法。